Literature DB >> 23899677

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Carolyn V Gould1, Jonathan R Edwards, Jessica Cohen, Wendy M Bamberg, Leigh Ann Clark, Monica M Farley, Helen Johnston, Joelle Nadle, Lisa Winston, Dale N Gerding, L Clifford McDonald, Fernanda C Lessa.   

Abstract

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

Entities:  

Keywords:  Clostridium difficile; clinical laboratory techniques; incidence; nucleic acid amplification techniques; surveillance

Mesh：

Year:  2013        PMID： 23899677      PMCID： PMC9580544          DOI： 10.1093/cid/cit492

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  14 in total

1.  Public reporting of Clostridium difficile and improvements in diagnostic tests.

Authors:  Simon D Goldenberg
Journal:  Infect Control Hosp Epidemiol       Date:  2011-12       Impact factor: 3.254

Review 2.  Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.

Authors:  John C O'Horo; Amy Jones; Matthew Sternke; Christopher Harper; Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

Review 3.  Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?

Authors:  Fred C Tenover; Ellen Jo Baron; Lance R Peterson; David H Persing
Journal:  J Mol Diagn       Date:  2011-08-18       Impact factor: 5.568

4.  Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?

Authors:  Kimberlee S Fong; Cynthia Fatica; Geraldine Hall; Gary Procop; Susan Schindler; Steven M Gordon; Thomas G Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09       Impact factor: 3.254

5.  Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules.

Authors: 
Journal:  Fed Regist       Date:  2011-08-18

6.  Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea.

Authors:  Steven W Johnson; Meganne Kanatani; Romney M Humphries; Daniel Z Uslan
Journal:  Am J Infect Control       Date:  2012-10-05       Impact factor: 2.918

7.  Is repeat PCR needed for diagnosis of Clostridium difficile infection?

Authors:  Robert F Luo; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

8.  Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.

Authors:  Bobby L Boyanton; Preethi Sural; Caroline R Loomis; Christine Pesta; Laura Gonzalez-Krellwitz; Barbara Robinson-Dunn; Paul Riska
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

9.  Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.

Authors:  Yves Longtin; Sylvie Trottier; Gilles Brochu; Bianka Paquet-Bolduc; Christophe Garenc; Vilayvong Loungnarath; Catherine Beaulieu; Danielle Goulet; Jean Longtin
Journal:  Clin Infect Dis       Date:  2012-09-25       Impact factor: 9.079

10.  Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes.

Authors:  E de Jong; A S de Jong; C J M Bartels; C van der Rijt-van den Biggelaar; W J G Melchers; P D J Sturm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-14       Impact factor: 3.267
View more
  35 in total

1.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

2.  Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions.

Authors:  Johanna Sandlund; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

3.  Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.

Authors:  Rebekah W Moehring; Eric T Lofgren; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-29       Impact factor: 3.254

4.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

5.  Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer.

Authors:  Mini Kamboj; Jennifer Brite; Tracy McMillen; Elizabeth Robilotti; Alejandro Herrera; Kent Sepkowitz; N Esther Babady
Journal:  J Infect       Date:  2017-12-08       Impact factor: 6.072

Review 6.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

7.  Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.

Authors:  Matthew M Hitchcock; Marisa Holubar; Catherine A Hogan; Lucy S Tompkins; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

8.  Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital.

Authors:  Nagham Khanafer; Philippe Vanhems; Frédéric Barbut; Catherine Eckert; Michel Perraud; François Vandenesch; Christine Luxemburger; Clarisse Demont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-17       Impact factor: 3.267

9.  Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Authors:  Alice Y Guh; Yi Mu; Lisa G Winston; Helen Johnston; Danyel Olson; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Ghinwa K Dumyati; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

Review 10.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.